Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16398403rdf:typepubmed:Citationlld:pubmed
pubmed-article:16398403lifeskim:mentionsumls-concept:C0205474lld:lifeskim
pubmed-article:16398403lifeskim:mentionsumls-concept:C0007131lld:lifeskim
pubmed-article:16398403lifeskim:mentionsumls-concept:C0027912lld:lifeskim
pubmed-article:16398403lifeskim:mentionsumls-concept:C0031437lld:lifeskim
pubmed-article:16398403lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:16398403lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:16398403pubmed:issue4lld:pubmed
pubmed-article:16398403pubmed:dateCreated2006-1-9lld:pubmed
pubmed-article:16398403pubmed:abstractTextThe prevalence and distribution of neuroendocrine differentiation in non-small cell lung cancer (NSCLC) was estimated by assays for synaptophysin (SYN), chromogranin A (CgA), Leu7 and neuron-specific enolase (NSE). Serum NSE and CgA were determined in parallel to find the values of these markers for distinguishing neuroendocrine differentiation in NSCLC. Fifty-eight resected NSCLC specimens and 34 sera of NSCLC patients entered the study. Neuroendocrine differentiation was graded according to the percentage of neuroendocrine tumor cells as NE0--0%, NE1-NE4--1%->76%. Serum NSE <12.5 ng/mL and serum CgA <46 U/L were taken as cutoff levels.lld:pubmed
pubmed-article:16398403pubmed:languageenglld:pubmed
pubmed-article:16398403pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16398403pubmed:citationSubsetIMlld:pubmed
pubmed-article:16398403pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16398403pubmed:statusMEDLINElld:pubmed
pubmed-article:16398403pubmed:issn0393-6155lld:pubmed
pubmed-article:16398403pubmed:authorpubmed-author:SlodkowskaJJlld:pubmed
pubmed-article:16398403pubmed:authorpubmed-author:ZychJJlld:pubmed
pubmed-article:16398403pubmed:authorpubmed-author:DemkowUUlld:pubmed
pubmed-article:16398403pubmed:authorpubmed-author:SzturmowiczMMlld:pubmed
pubmed-article:16398403pubmed:authorpubmed-author:Rowinska-Zakr...lld:pubmed
pubmed-article:16398403pubmed:authorpubmed-author:Roszkowski-Sl...lld:pubmed
pubmed-article:16398403pubmed:issnTypePrintlld:pubmed
pubmed-article:16398403pubmed:volume20lld:pubmed
pubmed-article:16398403pubmed:ownerNLMlld:pubmed
pubmed-article:16398403pubmed:authorsCompleteYlld:pubmed
pubmed-article:16398403pubmed:pagination217-26lld:pubmed
pubmed-article:16398403pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:16398403pubmed:meshHeadingpubmed-meshheading:16398403...lld:pubmed
pubmed-article:16398403pubmed:meshHeadingpubmed-meshheading:16398403...lld:pubmed
pubmed-article:16398403pubmed:meshHeadingpubmed-meshheading:16398403...lld:pubmed
pubmed-article:16398403pubmed:meshHeadingpubmed-meshheading:16398403...lld:pubmed
pubmed-article:16398403pubmed:meshHeadingpubmed-meshheading:16398403...lld:pubmed
pubmed-article:16398403pubmed:meshHeadingpubmed-meshheading:16398403...lld:pubmed
pubmed-article:16398403pubmed:meshHeadingpubmed-meshheading:16398403...lld:pubmed
pubmed-article:16398403pubmed:meshHeadingpubmed-meshheading:16398403...lld:pubmed
pubmed-article:16398403pubmed:meshHeadingpubmed-meshheading:16398403...lld:pubmed
pubmed-article:16398403pubmed:meshHeadingpubmed-meshheading:16398403...lld:pubmed
pubmed-article:16398403pubmed:meshHeadingpubmed-meshheading:16398403...lld:pubmed
pubmed-article:16398403pubmed:meshHeadingpubmed-meshheading:16398403...lld:pubmed
pubmed-article:16398403pubmed:meshHeadingpubmed-meshheading:16398403...lld:pubmed
pubmed-article:16398403pubmed:articleTitleNeuroendocrine phenotype of non-small cell lung carcinoma: immunohistological evaluation and biochemical study.lld:pubmed
pubmed-article:16398403pubmed:affiliationDepartment of Telepathology, The National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland. j.slodkowska@igichp.edu.pllld:pubmed
pubmed-article:16398403pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16398403pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed